The primary goal of pharmacotherapy in coronary artery disease is to:

Choice A rationale

While some beta-blockers have a minor effect on vasodilation, their primary purpose in a post-MI patient is not to dilate the coronary arteries. Beta-blockers reduce myocardial oxygen demand by decreasing heart rate, contractility, and blood pressure. Vasodilators, such as nitrates or calcium channel blockers, are the drugs of choice for dilating coronary arteries.

Choice B rationale

After an MI, circulating catecholamines (epinephrine and norepinephrine) can increase heart rate and contractility, which raises myocardial oxygen demand and can extend the size of the infarct. Metoprolol, a beta-blocker, competitively blocks these catecholamines at the beta-1 adrenergic receptors, thereby reducing heart rate and myocardial contractility. This action decreases oxygen consumption and prevents further cardiac damage.

Choice C rationale

Beta-blockers like metoprolol have a negative inotropic effect, meaning they decrease the force of myocardial contraction. A positive inotropic effect, which increases the force of contraction, is seen with drugs like digoxin or dopamine and would be counterproductive in a post-MI setting where the goal is to reduce the heart's workload.

Choice D rationale

While metoprolol does lower blood pressure as a secondary effect by decreasing heart rate and reducing cardiac output, its primary purpose in a post-MI patient is to reduce the workload of the heart and decrease myocardial oxygen demand. The reduction in blood pressure is a beneficial side effect, but it is not the main indication for its use in this context.

Choice A rationale

Reducing physical activity is not a recommended lifestyle modification for enhancing the effectiveness of antihypertensive medication. Regular physical activity, such as aerobic exercise, strengthens the cardiovascular system, helps manage weight, and can directly lower blood pressure, thereby complementing the effects of medication.

Choice B rationale

Increasing dietary sodium intake is detrimental to blood pressure control. High sodium intake leads to increased fluid retention, which raises blood volume and cardiac output, thereby increasing blood pressure. This counteracts the effect of antihypertensive medication and is a known risk factor for cardiovascular disease.

Choice C rationale

Limiting fluid intake is not a universally recommended strategy for all patients on antihypertensive medication. While some conditions like heart failure may require fluid restriction, this is not a general rule for hypertension management. Maintaining adequate hydration is important for overall health and for the proper function of various bodily systems.

Choice D rationale

Maintaining a low-sodium diet and managing weight are two critical lifestyle modifications that enhance the effectiveness of antihypertensive medication. A low-sodium diet reduces fluid retention and blood volume, while weight management decreases the strain on the heart and blood vessels. These actions work synergistically with medication to lower blood pressure.